Overview
Ehlers-Danlos syndrome cardiac valvular type primarily involves myxomatous degeneration of cardiac valves, often linked to genetic mutations affecting cytoskeletal proteins like Filamin A 1. This condition can present as an isolated cardiac phenotype or alongside connective tissue manifestations 1.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Fernández L, Tenorio J, Polo-Vaquero C, Vallespín E, Palomares-Bralo M, García-Miñaúr S et al.. In-frame Variants in FLNA Proximal Rod 1 Domain Associate With a Predominant Cardiac Valvular Phenotype. Revista espanola de cardiologia (English ed.) 2018. link 2 Elhoury ME, Faqeih E, Almoukirish AS, Galal MO. Cardiac involvement in geleophysic dysplasia in three siblings of a Saudi family. Cardiology in the young 2015. link 3 Rombaut L, Scheper M, De Wandele I, De Vries J, Meeus M, Malfait F et al.. Chronic pain in patients with the hypermobility type of Ehlers-Danlos syndrome: evidence for generalized hyperalgesia. Clinical rheumatology 2015. link 4 Martin DS, D'Aunno DS, Wood ML, South DA. Repetitive high G exposure is associated with increased occurrence of cardiac valvular regurgitation. Aviation, space, and environmental medicine 1999. link 5 Penmetcha M, Rosenbush SW, Harris CA. Cardiac valvular disease in scleroderma and systemic lupus erythematosus/scleroderma overlap associated with antiphospholipid antibodies. The Journal of rheumatology 1996. link 6 Sotaniemi KA. The benefits of open-heart surgery as reflected in the EEG. Scandinavian journal of thoracic and cardiovascular surgery 1981. link 7 Forshaw J, Harwood L. Red blood cell abnormalities in cardiac valvular disease. Journal of clinical pathology 1967. link